These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26397829)

  • 1. Effects of omega-3 supplementation on interleukin and neurotrophin levels in an animal model of schizophrenia.
    Zugno AI; Canever L; Mastella G; Heylmann AS; Oliveira MB; Steckert AV; Castro AA; dal Pizzol F; Quevedo J; Gama CS
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1475-86. PubMed ID: 26397829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
    Gama CS; Canever L; Panizzutti B; Gubert C; Stertz L; Massuda R; Pedrini M; de Lucena DF; Luca RD; Fraga DB; Heylmann AS; Deroza PF; Zugno AI
    Schizophr Res; 2012 Nov; 141(2-3):162-7. PubMed ID: 22954755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.
    Zugno AI; Chipindo HL; Volpato AM; Budni J; Steckert AV; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Mastella GA; Maravai SG; Wessler PG; Binatti AR; Panizzutti B; Schuck PF; Quevedo J; Gama CS
    Neuroscience; 2014 Feb; 259():223-31. PubMed ID: 24316471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizophrenia.
    Zugno AI; Chipindo H; Canever L; Budni J; Alves de Castro A; Bittencourt de Oliveira M; Heylmann AS; Gomes Wessler P; da Rosa Silveira F; Damázio LS; Mastella GA; Kist LW; Bogo MR; Quevedo J; Gama CS
    Life Sci; 2015 Jan; 121():65-9. PubMed ID: 25498892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal omega 3 fatty acid supplementation to a micronutrient imbalanced diet protects brain neurotrophins in both the cortex and hippocampus in the adult rat offspring.
    Sable PS; Kale AA; Joshi SR
    Metabolism; 2013 Nov; 62(11):1607-22. PubMed ID: 23845215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 5-HT₁A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism.
    Vines A; Delattre AM; Lima MM; Rodrigues LS; Suchecki D; Machado RB; Tufik S; Pereira SI; Zanata SM; Ferraz AC
    Neuropharmacology; 2012 Jan; 62(1):184-91. PubMed ID: 21740919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplementation of omega-3 fatty acid and circulating levels of interleukin-1beta, osteocalcin, and C-reactive protein in rats.
    Vardar-Sengül S; Buduneli N; Buduneli E; Kardeşler L; Baylas H; Atilla G; Lappin D; Kinane DF
    J Periodontol; 2006 May; 77(5):814-20. PubMed ID: 16671873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal omega-3 fatty acid supplementation on vitamin B12 rich diet improves brain omega-3 fatty acids, neurotrophins and cognition in the Wistar rat offspring.
    Rathod R; Khaire A; Kemse N; Kale A; Joshi S
    Brain Dev; 2014 Nov; 36(10):853-63. PubMed ID: 24418228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration.
    Fraga DB; Réus GZ; Abelaira HM; De Luca RD; Canever L; Pfaffenseller B; Colpo GD; Kapczinski F; Quevedo J; Zugno AI
    Braz J Psychiatry; 2013; 35(3):262-6. PubMed ID: 24142087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbic acid supplementation attenuates schizophrenia-like symptoms in an animal model induced by ketamine.
    Supp AD; Avila S; Mastella GA; Damásio L; de Oliveira IH; Godoi AK; Michels A; Schuck PF; Zugno AI
    Int J Dev Neurosci; 2021 Feb; 81(1):26-36. PubMed ID: 32780510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary omega-3 deficiency reduces BDNF content and activation NMDA receptor and Fyn in dorsal hippocampus: implications on persistence of long-term memory in rats.
    Bach SA; de Siqueira LV; Müller AP; Oses JP; Quatrim A; Emanuelli T; Vinadé L; Souza DO; Moreira JD
    Nutr Neurosci; 2014 Jul; 17(4):186-92. PubMed ID: 24621058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies.
    Issa G; Wilson C; Terry AV; Pillai A
    Neurobiol Dis; 2010 Sep; 39(3):327-33. PubMed ID: 20451611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model.
    Bousquet M; Gibrat C; Saint-Pierre M; Julien C; Calon F; Cicchetti F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1401-8. PubMed ID: 19632286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model.
    Mills JD; Bailes JE; Sedney CL; Hutchins H; Sears B
    J Neurosurg; 2011 Jan; 114(1):77-84. PubMed ID: 20635852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia.
    Zugno AI; Pacheco FD; Budni J; de Oliveira MB; Canever L; Heylmann AS; Wessler PG; da Rosa Silveira F; Mastella GA; Gonçalves CL; Freitas KV; de Castro AA; Streck EL; Quevedo J
    Metab Brain Dis; 2015 Aug; 30(4):1043-53. PubMed ID: 25920483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice.
    Ben-Azu B; Uruaka CI; Ajayi AM; Jarikre TA; Nwangwa KE; Chilaka KC; Chijioke BS; Omonyeme MG; Ozege CB; Ofili EC; Warekoromor EB; Edigbue NL; Esiekpe UV; Akaenyi DE; Agu GO
    Neurochem Res; 2023 Mar; 48(3):816-829. PubMed ID: 36350433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of acetylcholinesterase activity and behavioural alterations induced by ketamine in an animal model of schizophrenia.
    Zugno AI; Matos MP; Canever L; Fraga DB; De Luca RD; Ghedim FV; Deroza PF; de Oliveira MB; Pacheco FD; Valvassori SS; Volpato AM; Budni J; Quevedo J
    Acta Neuropsychiatr; 2014 Feb; 26(1):43-50. PubMed ID: 25142099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-generational trans fat intake facilitates mania-like behavior: oxidative and molecular markers in brain cortex.
    Trevizol F; Roversi K; Dias VT; Roversi K; Barcelos RC; Kuhn FT; Pase CS; Golombieski R; Veit JC; Piccolo J; Pochmann D; Porciúncula LO; Emanuelli T; Rocha JB; Bürger ME
    Neuroscience; 2015 Feb; 286():353-63. PubMed ID: 25499313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Amphetamine withdrawal-induced decreases in brain-derived neurotrophic factor in sprague-dawley rats are reversed by treatment with ketamine.
    Fuller JJ; Murray RC; Horner KA
    Neuropharmacology; 2015 Oct; 97():7-17. PubMed ID: 25986696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.
    Garcia LS; Comim CM; Valvassori SS; Réus GZ; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):502-6. PubMed ID: 19067677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.